EMA Presses On With Keenly-Awaited Guidance On How To Use Patient Experience Data

While the International Council of Harmonisation is developing a harmonized approach to patient-focused drug development, the European Medicines Agency has heeded calls for “prompt guidance” to support the systematic inclusion of patient experience data in regulatory submissions.